Literature DB >> 27860062

Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger.

Halima Boubacar Maïnassara1,2,3, Garba Idé Oumarou1, Bassira Issaka1, Ali Sidiki1, Issa Idi1, Jean-Paul Moulia Pelat1, Arnaud Fontanet2,4, Judith E Mueller2,5.   

Abstract

OBJECTIVE: To inform public health recommendations, we evaluated the effectiveness and efficiency of current and hypothetical surveillance and vaccine response strategies against Neisseria meningitidis C meningitis epidemics in 2015 in Niger.
METHODS: We analysed reports of suspected and confirmed cases of meningitis from the region of Dosso during 2014 and 2015. Based on a definition of epidemic signals, the effectiveness and efficiency of surveillance and vaccine response strategies were evaluated by calculating the number of potentially vaccine-preventable cases and number of vaccine doses needed per epidemic signal.
RESULTS: A total of 4763 weekly health area reports, collected in 90 health areas with 1282 suspected meningitis cases, were included. At a threshold of 10 per 100 000, the total number of estimated vaccine-preventable cases was 29 with district-level surveillance and vaccine response, 141 with health area-level surveillance and vaccination and 339 with health area-level surveillance and district-level vaccination. While being most effective, the latter strategy required the largest number of vaccine doses (1.8 million), similar to the strategy of surveillance and vaccination at district level (1.3 million), whereas the strategy of surveillance and vaccination at health area level would have required only 0.8 million doses. Thus, efficiency was lowest for district-level surveillance and highest for health area-level surveillance with district-level vaccination.
CONCLUSION: In this analysis, we found that effectiveness and efficiency were higher at health area-level surveillance and district-level vaccination than for other strategies. Use of N. meningitidis C vaccines in a preventive strategy thus should be considered, in particular as most reactive vaccine response strategies in our analysis had little impact on disease burden.
© 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Niger; epidemics; meningitis; response strategies; surveillance

Mesh:

Substances:

Year:  2016        PMID: 27860062     DOI: 10.1111/tmi.12815

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  5 in total

1.  Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.

Authors:  S M Niaz Arifin; Christoph Zimmer; Caroline Trotter; Anaïs Colombini; Fati Sidikou; F Marc LaForce; Ted Cohen; Reza Yaesoubi
Journal:  Med Decis Making       Date:  2019-07-03       Impact factor: 2.583

2.  The association between respiratory tract infection incidence and localised meningitis epidemics: an analysis of high-resolution surveillance data from Burkina Faso.

Authors:  Judith E Mueller; Maxime Woringer; Souleymane Porgho; Yoann Madec; Haoua Tall; Nadège Martiny; Brice W Bicaba
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

3.  Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.

Authors:  Didier Mounkoro; Christelle S Nikiema; Issaka Maman; Souleymane Sakandé; Catherine H Bozio; Haoua Tall; Adodo Yao Sadji; Berthe-Marie Njanpop-Lafourcade; Agoro Sibabe; Dadja E Landoh; Essofa O Abodji; Agbenoko Kodjo; Tsidi A Tamekloe; Téné Alima Essoh; Détèma W Maba; Bradford D Gessner; Jennifer C Moïsi
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

4.  Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.

Authors:  Laura V Cooper; Olivier Ronveaux; Katya Fernandez; Clement Lingani; Kadade Goumbi; Chikwe Ihekweazu; Marie-Pierre Preziosi; Antoine Durupt; Caroline L Trotter
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

5.  Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.

Authors:  Fati Sidikou; Caelin C Potts; Maman Zaneidou; Sarah Mbaeyi; Goumbi Kadadé; Marietou F Paye; Sani Ousmane; Bassira Issaka; Alexander Chen; How-Yi Chang; Djibo Issifou; Clement Lingani; Souleymane Sakande; Baruani Bienvenu; Ali Elhadji Mahamane; Alpha Oumar Diallo; Amadou Moussa; Issaka Seidou; Moussa Abdou; Ali Sidiki; Omar Garba; Sani Haladou; Jean Testa; Ricardo Obama Nse; Halima Boubacar Mainassara; Xin Wang
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.